Top

Published in:

01-09-2011

Intervention costs and cost-effectiveness for a multiple-risk-factor diabetes self-management trial for Latinas: economic analysis of ¡Viva Bien!

Authors: Debra P Ritzwoller, PhD, Anna S Sukhanova, MA, Russell E Glasgow, PhD, Lisa A Strycker, MA, Diane K King, PhD, Bridget Gaglio, PhD, Deborah J Toobert, PhD

Published in: Translational Behavioral Medicine | Issue 3/2011

Abstract

Information on cost-effectiveness of multiple-risk-factor lifestyle interventions for Latinas with diabetes is lacking. The aim of this paper is to evaluate costs and cost-effectiveness for ¡Viva Bien!, a randomized trial targeting Latinas with type 2 diabetes. We estimated 6-month costs; calculated incremental costs per behavioral, biologic, and quality-of-life change; and performed sensitivity analyses from health plan and participant perspectives. Recruitment, intervention, and participant costs were estimated at $45,896, $432,433, and $179,697, respectively. This translates to $4,634 in intervention costs per ¡Viva Bien! participant; $7,723 in both per unit reduction in hemoglobin A1c and per unit reduction in body mass index. Although costs may be higher than interventions that address one risk factor, potential risks for longer-term health-care costs are high for this at-risk group. Given the benefits of ¡Viva Bien!, cost reductions are recommended to enhance its efficiency, adoption, and long-term maintenance without diluting its effectiveness.

Ritzwoller, D. P., Toobert, D., Sukhanova, A., & Glasgow, R. E. (2006). Economic analysis of the Mediterranean Lifestyle Program for postmenopausal women with diabetes. The Diabetes Educator, 32, 761–769. PMID 16971709.PubMedCrossRef

der Bruggen MA, Jacobs-van, van Baal, P. H., Hoogenveen, R. T., et al. (2009). Cost-effectiveness of lifestyle modification in diabetic patients. Diabetes Care, 32, 1453–1458.CrossRef

Narayan, K. M. V., D'Agostino, R. B., Kirk, J. K., et al. (2008). Disparities in A1c levels between Hispanic and non-Hispanic white adults with diabetes. Diabetes Care, 31, 240–246.PubMed

Emanuele, N., Moritz, T., Klein, R., et al. (2009). Ethnicity, race, and clinically significant macular edema in the Veterans Affairs Diabetes Trial (VADT). Diabetes Research and Clinical Practice, 86, 104–110.PubMedCrossRef

McWilliams, J. M., Meara, E., Zaslavsky, A. M., & Ayanian, J. Z. (2009). Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage. Annals of Internal Medicine, 150, 505–515.PubMed

Lloyd-Jones, D., Adams, R., Carnethon, M., et al. (2009). Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 119, 480–486.PubMedCrossRef

Pandey, D. K., Labarthe, D. R., Goff, D. C., Jr., Chan, W., & Nichaman, M. Z. (2001). Community-wide coronary heart disease mortality in Mexican Americans equals or exceeds that in non-Hispanic Whites: the Corpus Christi Heart Project. The American Journal of Medicine, 10, 87.

Hunt, K. J., Williams, K., Resendez, R. G., et al. (2002). All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox". Diabetes Care, 25, 1557–1563.PubMedCrossRef

Slater, J., Selzer, F., Dorbala, S., et al. (2003). Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry). The American Journal of Cardiology, 92, 773–778.PubMedCrossRef

10.

Flegal, K. M., Carroll, M. D., Ogden, C. L., & Johnson, C. L. (2002). Prevalence and trends in obesity among US adults, 1999–2000. JAMA, 288, 1723–1727.PubMedCrossRef

11.

Maskarinec, G., Grandinetti, A., Matsuura, G., et al. (2009). Diabetes prevalence and body mass index differ by ethnicity: the Multiethnic Cohort. Ethnicity & Disease, 19, 49–55.

12.

Oster, N. V., Welch, V., Schild, L., et al. (2006). Differences in self-management behaviors and use of preventive services among diabetes management enrollees by race and ethnicity. Disease Management, 9, 167–175.PubMedCrossRef

13.

Melloni, C., Berger, J. S., Wang, T. Y., et al. (2010). Representation of women in randomized clinical trials of cardiovascular disease prevention. Circulation: Cardiovascular Quality and Outcomes, 3, 135–142.CrossRef

14.

Glasgow, R. E., Klesges, L. M., Dzewaltowski, D. A., Bull, S. S., & Estabrooks, P. (2004). The future of health behavior change research: what is needed to improve translation of research into health promotion practice? Annals of Behavioral Medicine, 27, 3–12. PMID 14979358.PubMedCrossRef

15.

The Diabetes Prevention Program Research Group. (2005). Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care, 28, 888–894.CrossRef

16.

Knowler, W. C., Fowler, S. E., Hamman, R. F., et al. (2009). 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet, 374, 1677–1686.PubMedCrossRef

17.

The Diabetes Prevention Program Research Group. (2003). Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care, 26, 36–47.CrossRef

18.

Toobert, D. J., Glasgow, R., Strycker, L. A., et al. (2003). Biologic and quality of life outcomes from the Mediterranean Lifestyle Program: a randomized clinical trial. Diabetes Care, 26, 2288–2293.PubMedCrossRef

19.

Toobert, D. J., Glasgow, R. E., & Radcliffe, J. L. (2000). Physiologic and quality of life outcomes from the Women's Lifestyle Heart Trial. Annals of Behavioral Medicine, 22, 1–9.PubMedCrossRef

20.

Toobert, D. J., Glasgow, R. E., Nettekoven, L., & Brown, J. E. (1997). Behavioral and psychosocial effects of intensive lifestyle management for women with coronary heart disease. Patient Education and Counseling, 35, 177–188.CrossRef

21.

Toobert, D. J., Strycker, L. A., Glasgow, R. E., et al. (2010). Viva bien!: overcoming recruitment challenges in a multiple-risk-factor diabetes trial. American Journal of Health Behavior, 34, 432–441.PubMed

22.

Osuna, D., Barrera, M. Jr., Strycker, L.A., et al. (2009). Methods for the cultural adaptation of a diabetes lifestyle intervention for latinas: an illustrative project. Health Promotion Practice [Epub ahead of print]

23.

Ritzwoller, D. P., Sukhanova, A., Gaglio, B., & Glasgow, R. E. (2009). Costing behavioral interventions: a practical guide to enhance translation. Annals of Behavioral Medicine, 37, 218–227.PubMedCrossRef

24.

Sukhanova, A., Ritzwoller, D. P., Alexander, G., et al. (2009). Cost analyses of a web-based behavioral intervention to enhance fruit and vegetable consumption. International Journal of Behavioral Nutrition and Physical Activity, 6, 92.PubMedCrossRef

25.

United States Department of Labor. Bureau of Labor Statistics (BLS). Retrieved October 7, 2010, from http://www.bls.gov.

26.

Renaud, S., de Lorgeril, M., Delaye, J., et al. (1995). Cretan Mediterranean diet for prevention of coronary heart disease. The American Journal of Clinical Nutrition, 61, 1360S–1367S.PubMed

27.

Sharma, A., Jofre-Bonet, M., Panca, M., Lawrenson, J. G., & Murdoch, I. (2010). Hospital-based glaucoma clinics: what are the costs to patients? Eye (London, England), 24, 999–1005.CrossRef

28.

Nguyen, H. Q., Maciejewski, M. L., Gao, S., et al. (2008). Health care use and costs associated with use of a health club membership benefit in older adults with diabetes. Diabetes Care, 31, 1562–1567.PubMedCrossRef

29.

Ball, S., & Golhofner, A. (2008). Comparison of a commercial weight loss program to a fitness center. Journal of Exercise Physiology, 11, 1–12. Retrieved February 23, 2011, from http://faculty.css.edu/tboone2/asep/BallJEPonlineJune2008.pdf.

30.

Center for Medical Technology Policy. Patient-Centered Outcomes Research Institute. Retrieved October 7, 2010, from http://www.cmtpnet.org/comparative-effectiveness/overview-of-the-patient-centered-outcomes-research-institute.

31.

Institute of Medicine, Committee on Quality Health Care in America. (2003). Crossing the quality chasm: a new health system for the 21st century. Washington: National Academies Press.

32.

Glasgow, R. E., Strycker, L. A., Kurz, D., et al. (2010). Recruitment for an internet-based diabetes self-management program: scientific and ethical implications. Annals of Behavioral Medicine, 40, 40–48.PubMedCrossRef

33.

Finkelstein, E. A., Troped, P. J., Will, J. C., & Palombo, R. (2002). Cost-effectiveness of a cardiovascular disease risk reduction program aimed at financially vulnerable women: the Massachusetts WISEWOMAN project. Journal of Women’s Health and Gender-Based Medicine, 11, 519–526.PubMedCrossRef

34.

Bennett, G. G., & Glasgow, R. E. (2009). The delivery of public health interventions via the Internet: actualizing their potential. Annual Review of Public Health, 30, 273–292.PubMedCrossRef

35.

Mechael, P., Batavia, H., Kaonga, N., et al. (2010). Barriers and gaps affecting mHealth in low and middle income countries: policy white paper datasheet. Report/White Paper. The Earth Institute Columbia University, mHealth Alliance.

36.

Kennedy, A., Reeves, D., Bower, P., et al. (2007). The effectiveness and cost effectiveness of a national lay-led self care support programme for patients with long-term conditions: a pragmatic randomised controlled trial. Journal of Epidemiology and Community Health, 61, 254–261.PubMedCrossRef

37.

Ayala, G. X., Vaz, L., Earp, J. A., Elder, J. P., & Cherrington, A. (2010). Outcome effectiveness of the lay health advisor model among Latinos in the United States: an examination by role. Health Education Research, 25, 815–840.PubMedCrossRef

38.

Sterman, J. (2006). Learning from evidence in a complex world. American Journal of Public Health, 96, 505–514.PubMedCrossRef

39.

National Cancer Institute. Cancer Intervention and Surveillance Modeling Network. Retrieved October 7, 2010, from http://cisnet.cancer.gov.

40.

Meenan, R. T., Stevens, V. J., Hornbrook, M. C., et al. (1998). Cost-effectiveness of a hospital-based smoking cessation intervention. Medical Care, 36, 670–678.PubMedCrossRef

41.

Tunis, S. R., Stryer, D. B., & Clancey, C. M. (2003). Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA, 290, 1624–1632. PMID 14506122.PubMedCrossRef

42.

Glasgow, R. E., Magid, D. J., Beck, A., Ritzwoller, D., & Estabrooks, P. A. (2005). Practical clinical trials for translating research to practice: design and measurement recommendations. Medical Care, 43, 551–557. PMID 15908849.PubMedCrossRef

43.

Medical Research Council. Leading science for better health. Retrieved February 23, 2011, from http://www.mrc.ac.uk/index.htm.

44.

Kessler, R., & Glasgow, R.E. (2010) A proposal to speed translation of healthcare intervention research into practice: dramatic change is needed. American Journal of Preventive Medicine (in press).

45.

Wing, R. R., & Hill, J. O. (2001). Successful weight loss maintenance. Annual Review of Nutrition, 21, 323–341.PubMedCrossRef

46.

Ornish, D., Brown, S. E., Scherwitz, L. W., et al. (1990). Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet, 336, 129–133.PubMedCrossRef

Title: Intervention costs and cost-effectiveness for a multiple-risk-factor diabetes self-management trial for Latinas: economic analysis of ¡Viva Bien!
Authors: Debra P Ritzwoller, PhD
Anna S Sukhanova, MA
Russell E Glasgow, PhD
Lisa A Strycker, MA
Diane K King, PhD
Bridget Gaglio, PhD
Deborah J Toobert, PhD
Publication date: 01-09-2011
Publisher: Springer-Verlag
Published in: Translational Behavioral Medicine / Issue 3/2011
Print ISSN: 1869-6716
Electronic ISSN: 1613-9860
DOI: https://doi.org/10.1007/s13142-011-0037-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Intervention costs and cost-effectiveness for a multiple-risk-factor diabetes self-management trial for Latinas: economic analysis of ¡Viva Bien!

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2011

Suicide risk management: development and analysis of a telephone-based approach to patient safety

Translation of the diabetes prevention program into a community mental health organization for individuals with severe mental illness: a case study

Youth advocacy for obesity prevention: the next wave of social change for health

Delivering a lifestyle and weight loss intervention to individuals in real-world mental health settings: lessons and opportunities

Translating clinical evidence to the community: a synopsis and comment on “Community wide interventions for increasing physical activity”

Effectively translating diabetes prevention: a successful model in a historically underserved community